Understanding the effects of stroke

CLINUVEL has today announced that its drug afamelanotide was well tolerated by the first three arterial ischaemic stroke (AIS) patients enrolled in a world first clinical trial (CUV801). Watch our new video explaining the pathology and treatment of stroke.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Get in Touch

3,298FansLike
1,442FollowersFollow
3,230SubscribersSubscribe

Latest Posts